Larson Financial Group LLC Raises Position in HCA Healthcare, Inc. (NYSE:HCA)

Larson Financial Group LLC lifted its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 29.4% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 938 shares of the company’s stock after acquiring an additional 213 shares during the quarter. Larson Financial Group LLC’s holdings in HCA Healthcare were worth $324,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently modified their holdings of the business. Atwood & Palmer Inc. bought a new position in HCA Healthcare during the first quarter valued at $28,000. Bartlett & CO. Wealth Management LLC grew its holdings in HCA Healthcare by 888.9% during the first quarter. Bartlett & CO. Wealth Management LLC now owns 89 shares of the company’s stock valued at $31,000 after purchasing an additional 80 shares during the period. ORG Partners LLC grew its holdings in HCA Healthcare by 344.0% during the first quarter. ORG Partners LLC now owns 111 shares of the company’s stock valued at $38,000 after purchasing an additional 86 shares during the period. Legacy Investment Solutions LLC grew its holdings in HCA Healthcare by 99.0% during the fourth quarter. Legacy Investment Solutions LLC now owns 191 shares of the company’s stock valued at $62,000 after purchasing an additional 95 shares during the period. Finally, Physician Wealth Advisors Inc. bought a new position in shares of HCA Healthcare in the fourth quarter worth $64,000. 62.73% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at HCA Healthcare

In other HCA Healthcare news, COO Jon M. Foster sold 15,698 shares of the business’s stock in a transaction on Tuesday, May 13th. The shares were sold at an average price of $369.32, for a total transaction of $5,797,585.36. Following the completion of the sale, the chief operating officer directly owned 12,646 shares in the company, valued at approximately $4,670,420.72. The trade was a 55.38% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 1.30% of the company’s stock.

HCA Healthcare Stock Down 0.5%

NYSE HCA opened at $360.91 on Friday. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.19 and a quick ratio of 1.06. The stock has a market capitalization of $86.82 billion, a PE ratio of 16.05, a PEG ratio of 1.27 and a beta of 1.47. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $417.14. The business’s 50-day moving average is $376.38 and its 200 day moving average is $344.00.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Friday, April 25th. The company reported $6.45 earnings per share for the quarter, topping analysts’ consensus estimates of $5.75 by $0.70. HCA Healthcare had a return on equity of 1,063.91% and a net margin of 8.07%. The firm had revenue of $18.32 billion for the quarter, compared to the consensus estimate of $18.26 billion. During the same quarter in the prior year, the business earned $5.36 EPS. The business’s revenue for the quarter was up 5.7% on a year-over-year basis. Sell-side analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, June 30th. Investors of record on Monday, June 16th were given a $0.72 dividend. The ex-dividend date of this dividend was Monday, June 16th. This represents a $2.88 annualized dividend and a yield of 0.80%. HCA Healthcare’s dividend payout ratio (DPR) is presently 12.81%.

Wall Street Analyst Weigh In

A number of research firms have recently commented on HCA. Robert W. Baird reaffirmed a “neutral” rating and issued a $336.00 price target (down from $396.00) on shares of HCA Healthcare in a report on Tuesday, April 15th. Stephens raised HCA Healthcare to a “strong-buy” rating in a research note on Monday, June 2nd. Royal Bank Of Canada reissued an “outperform” rating and set a $404.00 price objective (up previously from $376.00) on shares of HCA Healthcare in a research note on Monday, June 23rd. Truist Financial lifted their price objective on HCA Healthcare from $390.00 to $415.00 and gave the company a “buy” rating in a research note on Wednesday. Finally, Wells Fargo & Company raised HCA Healthcare from an “underweight” rating to an “equal weight” rating and lifted their price objective for the company from $320.00 to $385.00 in a research note on Thursday, May 29th. Eight investment analysts have rated the stock with a hold rating, ten have given a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $399.21.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.